The U.S. House of Representatives voted Wednesday to reform the copyright royalty distribution system by replacing the current arbitration panels with judges.
The U.S. House of Representatives voted Wednesday to raise patent fees and end the practice of fund diversion from the U.S. Patent & Trademark Office to other federal programs.
An Australian law reform commission has proposed reforms to the country’s patent law to protect Australia's genetic researchers from prosecution by companies that hold patents on genetic materials and technologies.
In a move that could kill efforts to extend copyright protection to database publishers, a committee of the U.S. House of Representatives on Wednesday approved a bill that sharply curtailed the protections that the industry had sought.
In a move designed to help generic drug makers, the U.S. Food and Drug Administration has decided to disclose on its website the date an acceptable generic application was received.
The Hamburg Stock Exchange is considering an innovative plan to trade patent rights, according to a published report.
The acting head of the U.S. Patent and Trademark Office, Jon Dudas, flew to China over the weekend for a week of consultations with his counterparts at China's intellectual property agencies.
The U.S. is expected to surpass Germany as the top filer of international trademark registrations after the country ratified the Madrid protocol of the World Intellectual Property Organization in November of last year.
U.S. Federal Reserve Chairman Alan Greenspan told a forum at Stanford University that the U.S. economy’s shift from commodities to intangible products has made intellectual property a major issue that will need to be addressed by economists and policy makers.
Canada’s competition watchdog sent a probe over price gouging by drug companies back to the federal government, suggesting it review the country’s current patent laws.
Last year’s decision by the U.S. Food and Drug Administration to limit 30-month stays in pharmaceutical patent challenges isn’t likely to ease the pathway to the market for generic makers, according to a new study.
The European Union’s controversial new legal framework for intellectual property enforcement is headed for final approval by mid-March, following months of delays amid protests from consumer advocates and civil-liberties groups.
Advocacy groups have asked the U.S. Patent and Trademark Office to revoke a patent granted to the University of Texas for a procedure for animal testing.
In a historic move, Malaysia’s government has issued the world’s first compulsory license, allowing a local firm to import patented anti-HIV/AIDS drugs from an Indian generic maker under fixed prices.
The European Parliament has postponed a vote on the controversial Enforcement of Intellectual Property Rights Directive until early next week amid drawn-out negotiations between the Irish presidency and the European Commission.
The European Council is circulating a “working paper” that would allow unlimited patentability and patent enforceability for computer software in the European Union, according to an advocacy group.
India’s Supreme Court has asked the government to file a petition at the European Patent Office challenging the granting of patent rights to U.S. agro-biotech multinational Monsanto on traditional Indian wheat landrace, Nap Hal.
A labor organization representing examiners at the U.S. Patent and Trademark Office is urging Congress to reject a bill that would raise patent fees for small businesses.
The World Health Organization has set up a commission to review how intellectual property rights affect the creation of new drugs against “diseases of poverty” in the developing world.
The European Parliament is expected to vote on the controversial Enforcement of Intellectual Property Rights Directive on Monday, following several months of delays as trade groups and consumer advocates sought to soften what they say are the bill’s draconian measures.